KP-001
- Generic Name
- KP-001
Phase 1 Crossover Study Evaluating the Safety, Tolerability, and Pharmacokinetics of KP001 in Healthy Adult Volunteers
- First Posted Date
- 2025-05-09
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Kokua Pharma Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT06963411
- Locations
- 🇨🇦
Syneos HealthClinique Inc., Quebec City, Quebec, Canada
To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in Volunteers
Phase 1
Recruiting
- Conditions
- Healty Volunteers
- Interventions
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Kaken Pharmaceutical
- Target Recruit Count
- 36
- Registration Number
- NCT06821698
- Locations
- 🇺🇸
Parexel International Early Phase Clinical Unit, Glendale, California, United States
A Study to Evaluate the Effects of KP-001 on the QT/QTc Intervals in Healthy Adults
Phase 1
Active, not recruiting
- Conditions
- Healthy Volunteers - Male and Female
- Interventions
- First Posted Date
- 2024-10-21
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Kaken Pharmaceutical
- Target Recruit Count
- 40
- Registration Number
- NCT06649942
- Locations
- 🇺🇸
Parexel Early Phase Clinical Unit - Los Angeles, Glendale, California, United States
A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of KP-001
- First Posted Date
- 2024-09-30
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Kaken Pharmaceutical
- Target Recruit Count
- 24
- Registration Number
- NCT06619054
A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants
Phase 1
Completed
- Conditions
- Healthy Adults
- Interventions
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- Kaken Pharmaceutical
- Target Recruit Count
- 38
- Registration Number
- NCT06227832
- Locations
- 🇺🇸
Parexel Early Phase Clinical Unit - Los Angeles, Glendale, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath